CONMED
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CONMED generated cash of $125,348,000, which is more than the previous year. Cash used in financing activities reached the amount of -$110,432,000 last year. Net change in cash is therefore -$4,646,000.
Cash Flow
| 2014 | 65.17M | -20.67M | -26.39M |
|---|---|---|---|
| 2015 | 48.06M | -24.36M | -9.77M |
| 2016 | 38.22M | -266.02M | 184.20M |
| 2017 | 65.56M | -29.05M | -34.88M |
| 2018 | 74.70M | -16.50M | -72.26M |
| 2019 | 95.13M | -387.66M | 300.88M |
| 2020 | 64.53M | -13.63M | -52.05M |
| 2021 | 111.77M | -14.86M | -101.54M |
| 2022 | 33.36M | -249.52M | 225M |
| 2023 | 125.34M | -20.03M | -110.43M |
CNMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 28.94M | 20.84M | 27.35M | 25.85M | 17.51M | 32.62M | 27.42M | 72.50M | 66.33M | 54.44M |
Operating activities | ||||||||||
Net income | 64.45M | -80.58M | 62.54M | 9.51M | 28.62M | 40.85M | 55.48M | 14.66M | 30.49M | 32.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 51.4M | 69.51M | 70.74M | 72.62M | 72.32M | 61.80M | 58.54M | 55.30M | 43.87M | 45.73M |
Stock-based compensation expense | 24.25M | 21.72M | 16.33M | 13.11M | 11.77M | 10.03M | 8.47M | 8.37M | 7.49M | 9.33M |
| Deferred income tax benefit | 24.25M | 21.72M | 16.33M | 13.11M | 11.77M | 10.03M | 8.47M | 8.37M | 7.49M | 9.33M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -47.06M | -5.20M | -9.15M | 13.92M | -13.94M | -17.46M | -13.63M | -6.38M | -9.64M | 5.25M |
Inventories | 14.07M | -78.56M | -37.80M | -30.39M | -117K | -15.03M | -3.92M | 3.10M | -34.53M | -20.94M |
Accounts payable | 14.84M | 13.30M | 4.89M | -2.97M | 38K | 12.10M | -286K | 2.09M | 11.50M | -3.44M |
Cash generated by operating activities | 125.34M | 33.36M | 111.77M | 64.53M | 95.13M | 74.70M | 65.56M | 38.22M | 48.06M | 65.17M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -19.03M | -21.78M | -14.86M | -13.01M | -20.06M | -16.50M | -12.84M | -14.75M | -15.00M | -15.41M |
Acquisitions Net | 0 | -227.74M | 0 | -3.85M | -367.59M | 0 | -16.21M | -256.45M | -9.35M | -5.26M |
Cash generated by investing activities | -20.03M | -249.52M | -14.86M | -13.63M | -387.66M | -16.50M | -29.05M | -266.02M | -24.36M | -20.67M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 72M | 0 | 0 | 30.56M | 0 | 0 | 0 | 0 | 29.31M |
Payments for dividends | -24.50M | -23.96M | -23.25M | -22.81M | -22.6M | -22.44M | -22.30M | -22.21M | -22.10M | -21.95M |
Repurchases of common stock | 0 | -72M | 0 | 0 | -30.56M | 0 | 0 | 0 | 0 | -16.86M |
Repayments of term debt | -88M | 362.01M | -460.40M | -225.25M | 362.85M | -182.69M | -12.20M | -171.09M | 29.44M | -1.14M |
Cash used in financing activities | -110.43M | 225M | -101.54M | -52.05M | 300.88M | -72.26M | -34.88M | 184.20M | -9.77M | -26.39M |
Net Change In Cash | -4.64M | 8.09M | -6.50M | 1.5M | 8.34M | -15.11M | 5.19M | -45.07M | 6.17M | 11.88M |
Cash at end of period | 24.29M | 28.94M | 20.84M | 27.35M | 25.85M | 17.51M | 32.62M | 27.42M | 72.50M | 66.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |